Fan Lian

Dr. Fan Lian


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2012 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YWYu Wang
Yu Wang
FLFan Lian
Fan Lian
JLJiaping Li
Jiaping Li
WFWenzhe Fan
Wenzhe Fan
HXHanshi Xu
Hanshi Xu
JYJianyong Yang
Jianyong Yang
Introduction: Adipose derived mesenchymal stem cells (ADMSCs), carrying the similar characteristics to bone marrow mesenchymal stem cells, only much more abundant and easier to obtain, may be a promising treatment for liver fibrosis. We aim to investigate the therapeutic potential of ADMSCs transplantation in liver fibrosis caused by carbon tetrachloride (CCl4) in rats as well as its underlying mechanism, and to further explore the appropriate infusion pathway. Methods: ADMSCs were isolated, cultured and identified. Placebo and ADMSCs were transplanted via portal vein and tail vein respectively into carbon tetrachloride (CCl4)-induced liver fibrosis rats. Computed tomography (CT) perfusion scan and microvessel counts were performed to measure the alteration of liver microcirculation after therapy. Liver function tests and histological findings were estimated. Results: CT perfusion scan shown significant decrease of hepatic arterial perfusion index, significant increased portal vein perfusion, total liver perfusion in rats receiving ADMSCs from portal vein, and Factor VIII (FVIII) immunohistochemical staining shown significant decrease of microvessels in rats receiving ADMSCs from portal vein, indicating microcirculation improvement in portal vein group. Vascular endothelial growth Factor (VEGF) was significantly up-regulated in fibrosis models, and decreased after ADMSCs intraportal transplantation. A significant improvement of liver functional test and histological findings in portal vein group were observed. No significance was found in rats receiving ADMSCs from tail vein. Conclusions: ADMSCs have a therapeutic effect against CCl4-mediated liver fibrosis. ADMSCs may benefit the fibrotic liver through alteration of microcirculation, evidenced by CT perfusion scan and down-regulation of VEGF. Intraportal transplantation is a better pathway than tail vein transplantation.

10 July 2019 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
YSYilin Song
Yilin Song
YWYule Wang
Yule Wang
YZYan Zhu
Yan Zhu
YCYu Cheng
Yu Cheng
YWYidan Wang
Yidan Wang
NLNan Li
Nan Li

6 March 2019 in Oncogene
Verified
Journal Article
Closed access
PDF file
YWYu Wang
Yu Wang
BXBin-Hui Xie
Bin-Hui Xie
WLWei-Hao Lin
Wei-Hao Lin
YHYong-Hui Huang
Yong-Hui Huang
JNJia-Yan Ni
Jia-Yan Ni
HLHeping Li
Heping Li

13 October 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
JZJun Zhou
Jun Zhou
YWYu Wang
Yu Wang
YLYiming Liu
Yiming Liu
HZHanjiang Zeng
Hanjiang Zeng
HXHanshi Xu
Hanshi Xu
FLFan Lian
Fan Lian

1 November 2013 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
SYShiwen Yuan
Shiwen Yuan
FLFan Lian
Fan Lian
DCDongying Chen
Dongying Chen
HLHao Li
Hao Li
QQQian Qiu
Qian Qiu
XYXiuyan Yang
Xiuyan Yang
Objective.: To evaluate the clinical characteristics of systemic lupus erythematosus (SLE)-induced abdominal pain in a cohort in South China and identify the risk factors for SLE-induced abdominal pain.Methods.: This is a retrospective cohort study of SLE patients with complaint of abdominal pain admitted to the first affiliated university hospital of Sun Yat-sen University between 2002 and 2011. Demographic information, clinical features, laboratory findings, SLE Disease Activity Index, and imaging characteristics were documented.Results.: Of the 3823 SLE patients reviewed, 213 patients complained of abdominal pain and 132 cases were considered SLE-induced. The most common causes were lupus mesenteric vasculitis (LMV; 73.5%, 97/132) and lupus pancreatitis (LP; 17.4%, 23/132). Other causes included appendicitis, acute gastroenteritis, and peritonitis. Univariate and multivariate logistic regression analysis indicated the European Consensus Lupus Activity Measurement (ECLAM) score was significantly associated with lupus-induced abdominal pain (OR = 1.858, 95% CI: 1.441–2.394, p < 0.001), LMV (OR = 1.713, 95% CI: 1.308-2.244, p < 0.001), and LP (OR = 2.153, 95% CI: 1.282, 3.617, p = 0.004). The serum D-dimer level (OR = 1.004, 95% CI: 1.002-1.005, p < 0.001) was a strongly associated factor for lupus-induced abdominal pain. Moderate and large amounts of ascetic fluid was significantly associated with lupus-induced abdominal pain and LMV. Elevated liver enzymes was a risk factor for LP (OR = 34.605, 95% CI: 3.591-333.472, p = 0.002).Conclusion.: LMV and LP were the leading causes of SLE-induced abdominal pain. The serum D-dimer was a strongly associated factor for lupus-induced abdominal pain. ECLAM score was a reliable index in assessment of SLE-associated abdominal pain. Elevated liver enzymes, and moderate or large amounts of ascites, were positively associated with lupus-induced abdominal pain.

25 October 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
JZJun Zhou
Jun Zhou
YWYu Wang
Yu Wang
FLFan Lian
Fan Lian
DCDongying Chen
Dongying Chen
QQQian Qiu
Qian Qiu
XYXiuyan Yang
Xiuyan Yang
Physical exercises and weight loss in obese patients help to improve uric acid Physical exercises and weight loss in obese patients help to improve uric acid